Seeing Is Believing
Healthcare - Sector
ADMA is currently covered by 4 analysts with an average price target of $19. This is a potential upside of $9.28 (95.47%) from yesterday's end of day stock price of $9.72.
ADMA Biologics's activity chart (see below) currently has 84 price targets and 73 ratings on display. The stock rating distribution of ADMA is 87.5% BUY and 12.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 76.25% with an average time for these price targets to be met of 851.07 days.
Highest price target for ADMA is $21, Lowest price target is $17, average price target is $19.
Most recent stock forecast was given by ANTHONY PETRONE from MIZUHO on 15-Jul-2026. First documented stock forecast 09-Sep-2015.
Currently out of the existing stock ratings of ADMA, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Jun-2019
$17
$7.28 (74.90%)
$20
2 months 20 days ago
(15-Jul-2026)
11/16 (68.75%)
$8.32 (95.85%)
570
Buy Since 10-May-2024
$21
$11.28 (116.05%)
$10
3 months 17 days ago
(18-Jun-2026)
1/2 (50%)
$12.69 (152.71%)
25
Buy Since 21-Apr-2026
$18
$8.28 (85.19%)
$21
4 months 28 days ago
(07-May-2026)
1/3 (33.33%)
$9.53 (112.51%)
209
Hold Since 12-Apr-2026
5 months 23 days ago
(12-Apr-2026)
9/10 (90%)
$7.99 (46.97%)
126
Buy Since 12-Oct-2018
$32
$22.28 (229.22%)
$25
1 years 4 months 27 days ago
(08-May-2025)
6/8 (75%)
$10.8 (50.94%)
1093
What is ADMA (ADMA Biologics) average time for price targets to be met?
Which analyst most recently updated their price target on ADMA (ADMA Biologics)?
Which analyst has the most public recommendations on ADMA (ADMA Biologics)?
Which analyst is the currently most bullish on ADMA (ADMA Biologics)?
Which analyst is the currently most reserved on ADMA (ADMA Biologics)?